New large-scale genetic analyses are reshaping how scientists understand mental illness, revealing that many psychiatric disorders arise from a surprisingly small set of shared genetic factors. Emerging evidence suggests these conditions are more biologically similar than current diagnoses imply.
Two landmark studies published in 2024 and 2025 examined genetic data from millions of people worldwide. Researchers report that just a handful of underlying genetic patterns account for most of the inherited risk across a wide range of psychiatric disorders.
Massive DNA studies of the brain
In the most recent study, scientists analyzed DNA from more than 1,000,000 individuals diagnosed with at least one of 14 psychiatric disorders. Their data were compared with genetic profiles from approximately 5,000,000 people without a psychiatric diagnosis.
By scanning the entire genome, the researchers searched for genetic variants that were more common among people with mental illness. They then used advanced statistical methods to group these risk signals into broader patterns that could explain vulnerability across multiple conditions.
The researchers identified five distinct genetic clusters that together account for the majority of heritable risk. These patterns cut across existing diagnostic labels, suggesting that traditional psychiatric categories often separate conditions that share common biological foundations.
Five genetic clusters emerge
One cluster links disorders characterized by compulsive thoughts and behaviors, including obsessive-compulsive disorder, anorexia nervosa, and Tourette syndrome. Shared genetic influences may help explain why these conditions frequently co-occur and often respond to similar treatment approaches.
A second cluster connects depression, anxiety, and post-traumatic stress disorder. These disorders commonly occur together in clinical practice, and their genetic overlap supports efforts to develop therapies targeting broader mood and stress-related pathways.
A third cluster centers on substance use disorders, including alcohol dependence and other forms of addiction. The genetic signatures within this group appear distinct from those associated with mood or compulsive disorders, reinforcing the view that addiction represents a partially separate biological domain.
The fourth cluster includes neurodevelopmental conditions such as autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD). Shared genetic factors may partly explain overlapping difficulties involving attention, learning, and social functioning.
The fifth, and perhaps most striking, cluster links schizophrenia and bipolar disorder. The analysis suggests that approximately 70% of the genetic signal associated with schizophrenia is also present in bipolar disorder, raising questions about how distinctly these illnesses should be classified.
Schizophrenia and bipolar disorder overlap
Clinically, schizophrenia and bipolar disorder are diagnosed based on different combinations of hallucinations, delusions, mood disturbances, and cognitive symptoms. However, many patients exhibit characteristics of both conditions, making diagnosis and treatment more challenging.
Genetic evidence indicating that these disorders share most of their inherited risk suggests they may exist along a spectrum rather than representing completely separate diseases. This insight could influence future diagnostic classifications and encourage more integrated treatment strategies.
Researchers argue that a biology-first approach could eventually complement or even replace today’s symptom-based diagnostic system. Instead of developing separate treatments for each diagnosis, future therapies may target the biological pathways shared across psychotic and mood disorders.
The role of pleiotropic genes
The new findings build upon research published in 2019 that identified 109 genes contributing, in different combinations, to eight major psychiatric disorders. Many of these genes are active during brain development and influence how neurons develop, connect, and communicate.
In a 2024 study, researchers examined nearly 18,000 genetic variants associated with those eight disorders. They introduced these variants into early brain precursor cells to investigate how they affected gene activity during critical stages of brain development.
The researchers identified 683 variants that significantly altered gene regulation and then tested their effects in developing mouse neurons. Their focus was on so-called pleiotropic variants—genetic changes that influence multiple traits or disorders rather than a single condition.
Pleiotropic variants participated in a greater number of protein-to-protein interactions and were active across more types of brain cells than variants associated with only one disorder. They also influenced regulatory networks involved in multiple stages of brain maturation.
This broad biological influence may explain why the same genetic changes can increase the risk of several psychiatric disorders depending on a person’s other genetic factors and life experiences. It also suggests that targeting pleiotropic pathways could eventually make it possible to treat multiple psychiatric conditions using similar therapeutic approaches.
Implications for diagnosis and treatment
Researchers emphasize that genetics represent only part of the picture. Environmental factors—including trauma, poverty, substance use, and early-life stress—play a major role in determining whether genetic susceptibility develops into mental illness and how severe that illness becomes.
Nevertheless, understanding the shared genetic architecture of psychiatric disorders could help identify individuals at increased risk earlier in life, before symptoms become fully established. It may also reveal biological pathways that offer promising targets for new medications and personalized treatment strategies.
Current psychiatric diagnostic systems rely primarily on observable symptoms and patients’ self-reported experiences. The new genetic evidence suggests that some disorders currently classified separately may arise from highly similar biological mechanisms, supporting a more integrated understanding of mental health.
According to the World Health Organization, nearly 1 billion people worldwide live with a psychiatric condition. Even modest improvements in prevention, early detection, or treatment could therefore have a substantial global impact.
The findings have been reported in leading scientific journals, including Cell and Nature, between 2019 and 2025, and continue to evolve as larger genetic datasets become available. Researchers stress that future studies combining genetics, brain imaging, and environmental information will be essential for translating these discoveries into improved patient care.
